{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6581c747f319b800172d9757/6581c74f1b4a06001743e656?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"A homegrown vaccine?","description":"<p>As results of the first human trials of Oxford University vaccine show immune reaction produced without any serious adverse reactions, virologist Dr Elisabetta Groppelli joins Theodora Louloudis to discuss why she thinks the results are ‘very, very encouraging’, whether a vaccine is ‘one size fits all’ and how virus mutation could affect crucial immunology research.</p><p>Read more about the potential coronavirus treatment from Synairgen: <a href=\"https://bit.ly/2WG5Fzr\" target=\"_blank\">https://bit.ly/2WG5Fzr</a></p><p>Read more about Test and Trace privacy allegations: https://bit.ly/2WEPdPS</p><p>Read more about French face masks: https://bit.ly/3fMPSq6</p><p>For 30 days' free access to The Telegraph:&nbsp;<a href=\"http://www.telegraph.co.uk/audio\" target=\"_blank\">www.telegraph.co.uk/audio</a></p><p>Email:&nbsp;<a href=\"mailto:coronaviruspodcast@telegraph.co.uk\" target=\"_blank\">coronaviruspodcast@telegraph.co.uk</a></p><p>See Privacy Policy at <a href=\"https://art19.com/privacy\" rel=\"noopener noreferrer\" target=\"_blank\">https://art19.com/privacy</a> and California Privacy Notice at <a href=\"https://art19.com/privacy#do-not-sell-my-info\" rel=\"noopener noreferrer\" target=\"_blank\">https://art19.com/privacy#do-not-sell-my-info</a>.</p>","author_name":"The Telegraph"}